title: [Prevention and treatment during the postmenopausal period].
abstract: Osteoporosis will always be a subject of human interest. Thus, it has to be governed by general laws, which-in medicine-still too often differ from the latest truths of nature, to pamper to some fashionable medical views. Its diagnosis makes the doctor feel good, because it explains the cause of the symptoms or disorders. The process of osteoporosis clearly intensifies in the period of climax and therefore, not only the menopause but also the symptoms of climacteric syndrome, anovulatory cycles after 35 years of life, past hemorrhages connected with pregnancy, infections of mammary glands in puerperium involving lack or shortening down to 3 months of natural breast-feeding, states after treatment of sterility, and particularly the infertility, as well as after excessively prolonged use of oral contraception, are indications for diagnostic examination. The aforesaid limit of 35 years of age allows the commencement of prophylactic hormonal prevention of postmenopausal disorders and diseases a lot earlier (more than ten years), instead of their belated-literally substitutive-treatment. The most appropriate are physiological doses, which-by supporting the endogenic natural source-treat without post-pharmacological side-effects, of which the most frequent are unwanted postmenopausal bleeding and/or hemorrhages from the genital tract. The principal rule of postmenopausal hormonal treatment is to adjust not only to the doctors orders, but also to one's own feeling and the estimated effectiveness of currently administered doses.
authors.affiliation: Katedry Endokrynologii i Plodności Collegium Medicum Uniwersytetu Jagiellońsklego w Krakowie.
authors.forename: R
authors.initials: R
authors.lastname: Klimek
mesh_terms: D000328:Adult; D005260:Female; D006728:Hormones / Q000008:administration & dosage; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D015663:Osteoporosis, Postmenopausal / Q000628:therapy*; D011247:Pregnancy; D014592:Uterine Hemorrhage / Q000517:prevention & control
chemical_list: D006728:Hormones